PRIO WEALTH LIMITED PARTNERSHIP - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 53 filers reported holding MERSANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
PRIO WEALTH LIMITED PARTNERSHIP ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$105,410
+93.1%
23,5290.0%0.00%
+50.0%
Q4 2023$54,588
+82.7%
23,5290.0%0.00%
+100.0%
Q3 2023$29,882
-61.4%
23,5290.0%0.00%
-66.7%
Q2 2023$77,411
-20.0%
23,5290.0%0.00%
-25.0%
Q1 2023$96,705
-29.9%
23,5290.0%0.00%
-33.3%
Q4 2022$137,880
-13.3%
23,5290.0%0.01%
-14.3%
Q3 2022$159,056
+46.3%
23,5290.0%0.01%
+75.0%
Q2 2022$108,704
+115542.6%
23,5290.0%0.00%
+33.3%
Q1 2022$94
-99.9%
23,5290.0%0.00%
-25.0%
Q4 2021$146,000
-34.2%
23,5290.0%0.00%
-42.9%
Q3 2021$222,000
-30.6%
23,5290.0%0.01%
-36.4%
Q2 2021$320,000
-16.0%
23,5290.0%0.01%
-21.4%
Q1 2021$381,000
-39.1%
23,5290.0%0.01%
-39.1%
Q4 2020$626,000
+42.9%
23,5290.0%0.02%
+27.8%
Q3 2020$438,000
-20.5%
23,5290.0%0.02%
-28.0%
Q2 2020$551,000
+302.2%
23,5290.0%0.02%
+212.5%
Q1 2020$137,000
+1.5%
23,5290.0%0.01%
+33.3%
Q4 2019$135,000
+264.9%
23,5290.0%0.01%
+200.0%
Q3 2019$37,000
-61.1%
23,5290.0%0.00%
-50.0%
Q2 2019$95,000
-22.8%
23,5290.0%0.00%
-33.3%
Q1 2019$123,000
+29.5%
23,5290.0%0.01%
+20.0%
Q4 2018$95,000
-59.6%
23,5290.0%0.01%
-54.5%
Q3 2018$235,000
-44.0%
23,5290.0%0.01%
-47.6%
Q2 2018$420,000
+13.2%
23,5290.0%0.02%
+16.7%
Q1 2018$371,00023,5290.02%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 818,033$14,144,00022.27%
ProQuest Associates IV LLC 955,709$16,524,00016.55%
NEA Management Company, LLC 8,144,267$140,814,0004.93%
Rock Springs Capital Management LP 1,330,000$22,996,0001.06%
Cormorant Asset Management, LP 295,549$5,110,0000.90%
ArrowMark Colorado Holdings LLC 477,711$8,260,0000.09%
Spark Investment Management LLC 18,688$323,0000.02%
WELLINGTON MANAGEMENT GROUP LLP 2,391,404$41,348,0000.01%
TUDOR INVESTMENT CORP ET AL 20,000$346,0000.01%
Laurion Capital Management LP 50,000$865,0000.00%
View complete list of MERSANA THERAPEUTICS INC shareholders